BioXcel Therapeutics Inc (BTAI) is around the top of the Biotechnology industry according to InvestorsObserver. BTAI received an overall rating of 85, which means that it scores higher than 85 percent of all stocks. BioXcel Therapeutics Inc also achieved a score of 98 in the Biotechnology industry, putting it above 98 percent of Biotechnology stocks. Biotechnology is ranked 26 out of the 148 industries.
What do These Ratings Mean?
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With BioXcel Therapeutics Inc Stock Today?
BioXcel Therapeutics Inc (BTAI) stock is lower by -3.89% while the S&P 500 is up 0.33% as of 3:19 PM on Friday, Jan 8. BTAI is down -$2.14 from the previous closing price of $54.95 on volume of 485,305 shares. Over the past year the S&P 500 is higher by 16.55% while BTAI is up 330.75%. BTAI lost -$3.37 per share the over the last 12 months.
Click Here to get the full Stock Score Report on BioXcel Therapeutics Inc (BTAI) Stock.
